Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia
NCT05889156
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
High Triglycerides
Interventions
DRUG:
NST-1024
OTHER:
Placebo
Sponsor
NorthSea Therapeutics B.V.